Mindpeak: Top 50 Digital Health Company 2024

Mindpeak Named to CB Insights' 2024 List of the 50 Most Innovative Digital Health Companies Worldwide

Mindpeak GmbH, global innovator in AI-driven digital pathology, has been named to CB Insights’ prestigious Digital Health 50 list for 2024. This recognition highlights the world’s most promising digital health companies, selected from over 10,000 candidates based on their innovation, market potential, and industry impact.

Recognized as a leader in AI-driven pathology solutions, Mindpeak is advancing cancer diagnostics with deep learning-powered tissue analysis technologies. (Picture: Mindpeak)
Recognized as a leader in AI-driven pathology solutions, Mindpeak is advancing cancer diagnostics with deep learning-powered tissue analysis technologies. (Picture: Mindpeak)

“The 2024 Digital Health 50 cohort highlights high-momentum companies driving meaningful change across healthcare,” said Amrit Panjabi, Intelligence Analyst at CB Insights. “This year’s winners are at the forefront of bringing an AI-driven infrastructure to healthcare, transforming diagnostics, and bringing condition-specific care platforms to patients and providers. These companies are accelerating the transformation of healthcare delivery, streamlining workflows, and advancing patient outcomes globally.”

With its world-leading, clinical-grade AI solutions for pathology, Mindpeak is revolutionizing cancer diagnostics on a global scale. Its algorithms were among the first to be deployed for routine clinical diagnostics, solidifying the company’s leadership in the field. Integrated into more image management platforms than any competitor, its solutions enable seamless adoption and broad accessibility.  

“We are proud to have earned a place on CB Insights’ Digital Health 50 list,” said Felix Faber, Co-Founder and CEO of Mindpeak. “Our mission is to empower healthcare professionals by improving the accuracy and efficiency of pathological diagnosis. Through our AI-driven solutions, we support pathologists in enhancing diagnostic workflows, enabling faster and more precise results. This recognition reaffirms our commitment to advancing innovation in cancer care.”

More News

Certification under the EU's In Vitro Diagnostic Regulation validates Mindpeak's quality management system, confirming it meets the EU's most rigorous standard for cancer-related diagnostic devices. (Image: Mindpeak)
Certification under the EU's In Vitro Diagnostic Regulation validates Mindpeak's quality management system, confirming it meets the EU's most rigorous standard for cancer-related diagnostic devices - a milestone for the Hamburg-based AI diagnostics company as it deepens partnerships across Europe. (Image: Mindpeak)

Mindpeak Earns IVDR Certification

Mindpeak, a leading developer of AI-powered software for digital pathology, announced it has achieved certification under the EU In Vitro Diagnostic Medical Devices Regulation (IVDR). ...

Read more …
Certification under the EU's In Vitro Diagnostic Regulation validates Mindpeak's quality management system, confirming it meets the EU's most rigorous standard for cancer-related diagnostic devices. (Image: Mindpeak)
Certification under the EU's In Vitro Diagnostic Regulation validates Mindpeak's quality management system, confirming it meets the EU's most rigorous standard for cancer-related diagnostic devices - a milestone for the Hamburg-based AI diagnostics company as it deepens partnerships across Europe. (Image: Mindpeak)

Mindpeak Earns IVDR Certification

Mindpeak, a leading developer of AI-powered software for digital pathology, announced it has achieved certification under the EU In Vitro Diagnostic Medical Devices Regulation (IVDR). ...

Read more …
Dr. Fernando Delgado (CTO), Dr. Michael Hartung (CPO), Alexander Zahn (CEO), and Prof. Dr. Jan Baumbach (CSO) (from left) founded the company in Hamburg in 2025. (Photo: Galagos)
Dr. Fernando Delgado (CTO), Dr. Michael Hartung (CPO), Alexander Zahn (CEO), and Prof. Dr. Jan Baumbach (CSO) (from left) founded the company in Hamburg in 2025. (Photo: Galagos)

#NEWatLSN: Galagos

We are delighted to welcome Galagos as a new member of Life Science Nord e.V.! The founding team answered questions about the company’s initial goals, ...

Read more …